Skip to Main Content

Paper Details

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease.
Front Immunol
7
2023
Author NameAffiliation
Georgios TsivgoulisAttikon University Hospital, National and Kapodistrian University of Athens
Georgios TsivgoulisThe University of Tennessee Health Science Center
  • 1 - 2

Datasets

Release 1.2